GHRP-2
Also known as: Pralmorelin, KP-102
Clinical Status
Approved in some countries for GH deficiency diagnosis.
Mechanism of Action
Acts on ghrelin receptors to stimulate GH release. Has the strongest GH-releasing effect among GHRPs but also causes more cortisol and prolactin release than ipamorelin.
Dosing Defaults
Dose
100-300 mcg
Frequency
2-3x daily
Administration
Subcutaneous injection
Timing
Before bed or morning (fasted)
Food
fasted
Duration
8-12 weeks
Dose range: 100-300 mcg per dose
Most effective fasted. Aligns with natural GH pulsatile release patterns.
Side Effects
- •Increased appetite
- •Water retention
- •Fatigue
- •Headache
- •Nausea
- •May elevate cortisol and prolactin
Contraindications & Warnings
- ⚠Active malignancies
- •Not medical advice
Compare
Compare GHRP-2 with another peptide side-by-side.
Ad
Related Growth Hormone Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.